Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BAY1905254 |
Trade Name | |
Synonyms | BAY 1905254|BAY-1905254 |
Drug Descriptions |
BAY1905254 is an antibody that specifically binds to and inhibits the immunosuppressive activity of ILDR2, potentially resulting in improved anti-tumor immune response (Cancer Res 2018;78(13 Suppl):Abstract nr 2778, PMID: 32312711). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C156490 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BAY1905254 | BAY1905254 | 0 | 1 |
BAY1905254 + Pembrolizumab | BAY1905254 Pembrolizumab | 0 | 1 |